2023/05 Kobe’s BioPalette develops genetically modified enterobacteria for microbiome therapy
https://bio.nikkeibp.co.jp/atcl/news/p1/23/04/25/10628/ https://www.biopalette.co.jp BioPalette is a Kobe University startup established in February 2017 based on research results from Kobe University. Professor Keiji Nishida and his research team at Kobe University’s Research Center for Advanced Biotechnology have developed “Target-AID” and “Target-G,” base-editing technologies that can rewrite bases without cutting DNA, among other genome editing technologies. Target-AID” uses […]